123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
about
Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciencesTYR as a multifunctional reporter gene regulated by the Tet-on system for multimodality imaging: an in vitro studyMelanin-targeted preclinical PET imaging of melanoma metastasis.Melanin as a potential target for radionuclide therapy of metastatic melanoma.Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy.Targeting Nanocarriers with Anisamide: Fact or Artifact?Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumorsEarly detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.High resolution magic angle spinning NMR spectroscopy used to investigate the ability of drugs to bind to synthetic melanin.PET and SPECT imaging of melanoma: the state of the art.Development of gadolinium based nanoparticles having an affinity towards melanin.In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.
P2860
Q24795884-CF1F5F7D-23A3-421A-8D3C-7CCAD1B0127CQ30399658-D95642E3-1106-4131-9542-A3DF2B74B7C5Q34430797-B3027EFE-D764-493C-A059-6CC8882087D3Q36429546-1EBA4A4B-1A20-433D-A6E9-3AF315253361Q36580750-96586002-01A6-44F5-BD26-991BE2E44C9CQ37505658-0CBEEFD0-31B6-4991-BD35-9AC4195E7E03Q39019352-4E4B3C06-4A50-4A97-B869-5331EC8CE01BQ39883067-48F4B5A6-C118-4DCB-8DA3-6AA5E7D6F3DBQ43480586-6C36D5AE-F221-4794-8654-C7BE7AB055D5Q45222839-FE620397-FF3B-45B7-9073-400B6E1B2E42Q47868574-C5DCF2DB-E469-4745-B000-1A654D60DE1AQ51534151-E2819E70-57DE-4F60-86C5-01336D7AA422Q53120428-3C373B61-496D-43D3-89E8-412C8C964836
P2860
123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
123I-N-
@nl
123I-N-(2-diethylaminoethyl)-2 ...... or cutaneous melanoma staging.
@en
type
label
123I-N-
@nl
123I-N-(2-diethylaminoethyl)-2 ...... or cutaneous melanoma staging.
@en
prefLabel
123I-N-
@nl
123I-N-(2-diethylaminoethyl)-2 ...... or cutaneous melanoma staging.
@en
P2093
P1476
123I-N-(2-diethylaminoethyl)-2 ...... or cutaneous melanoma staging.
@en
P2093
Annie Veyre
Danièle Mestas
Elisabeth Noirault
Eric Berthommier
Florence Chossat
Franck Bacin
Jacques Bonafous
Janine Papon
Jean-Claude Madelmont
Marie-France Moreau
P2888
P304
P356
10.1007/S00259-002-0971-6
P577
2002-09-11T00:00:00Z